Francisco Gea

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

José Luís Calleja, Javier Crespo, Diego Rincón et al. · Journal of Hepatology · 2017 · 187 citations

Direct-acting Antiviral Therapy, Viral Hepatitis, Antiviral Drug Development +10

Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis

Luís Rábago, Cristina de Vicente, María Delgado et al. · Endoscopy · 2006 · 127 citations

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

Jordi Llaneras, Mar Riveiro‐Barciela, Sabela Lens et al. · Journal of Hepatology · 2019 · 95 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +7

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

Sonia Alonso López, María Luisa Manzano, Francisco Gea et al. · Hepatology · 2020 · 93 citations

Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis

J. Enrique Domínguez‐Muñoz, Fernando Carballo, María Jesús García García et al. · Digestive Diseases and Sciences · 1993 · 57 citations

Inflammation, Pancreatic Fluid Collection, Immunology +8